Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
Clinical trial NCT00563836 · COMPLETED
Trial details
- NCT number
- NCT00563836
- Sponsor
- Neovii Biotech
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-09-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.